The success of ePA with GLP-1s will be a bellwether for how well the healthcare system can handle specialty medications at scale
Key physiological features include: Filaggrin gene mutations , leading to a compromised skin barrier and increased transepidermal water loss Th2-skewed immune response , with elevated IL-4, IL-13, and IgE levels Colonization with Staphylococcus aureus , often contributing to inflammation and secondary infection Heightened mast cell activity , promoting pruritus and dermal reactivity This pathophysiology supports a dual treatment approach: barrier repair and inflammation modulation , often in combination with antimicrobial or immunosuppressive strategies
The test analyzes variants in GIPR (rs1800437) genes, among 150+ insights across 14 pathways, which correlate with overall medication sensitivity rather than itching specifically
R., Wang, T., Wu, R., Chen, X., Liu, L
A: The minimum quantity we can order is 1 kg